ATE456656T1 - Isolierte gene aus säuger monozyten und betreffende reagentien - Google Patents

Isolierte gene aus säuger monozyten und betreffende reagentien

Info

Publication number
ATE456656T1
ATE456656T1 AT97952202T AT97952202T ATE456656T1 AT E456656 T1 ATE456656 T1 AT E456656T1 AT 97952202 T AT97952202 T AT 97952202T AT 97952202 T AT97952202 T AT 97952202T AT E456656 T1 ATE456656 T1 AT E456656T1
Authority
AT
Austria
Prior art keywords
monocytes
mammal
related reagents
isolated genes
reagents
Prior art date
Application number
AT97952202T
Other languages
English (en)
Inventor
Gosse Adema
Linde Meyaard
Daniel Gorman
Terrill Mcclanahan
Sandra Zurawski
Gerard Zurawski
Lewis Lanier
Joseph Phillips
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE456656T1 publication Critical patent/ATE456656T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97952202T 1996-12-06 1997-12-05 Isolierte gene aus säuger monozyten und betreffende reagentien ATE456656T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3225296P 1996-12-06 1996-12-06
US76218796A 1996-12-09 1996-12-09
US3318196P 1996-12-16 1996-12-16
US4127997P 1997-03-21 1997-03-21
PCT/US1997/021101 WO1998024906A2 (en) 1996-12-06 1997-12-05 Isolated mammalian monocyte cell genes; related reagents

Publications (1)

Publication Number Publication Date
ATE456656T1 true ATE456656T1 (de) 2010-02-15

Family

ID=27487977

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952202T ATE456656T1 (de) 1996-12-06 1997-12-05 Isolierte gene aus säuger monozyten und betreffende reagentien

Country Status (9)

Country Link
EP (2) EP2161338A1 (de)
JP (4) JP4156034B2 (de)
AT (1) ATE456656T1 (de)
AU (1) AU5587298A (de)
CA (1) CA2273196C (de)
DE (1) DE69739751D1 (de)
ES (1) ES2338283T3 (de)
PT (1) PT948623E (de)
WO (1) WO1998024906A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105303A1 (en) 1996-12-06 2003-06-05 Schering Corporation, A New Jersey Corporation Isolated mammalian monocyte cell genes; related reagents
US20060078564A1 (en) 2002-05-08 2006-04-13 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
US6448035B1 (en) 1997-04-24 2002-09-10 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
US6384203B1 (en) 1999-05-12 2002-05-07 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
CA2306246A1 (en) * 1997-10-06 1999-04-15 Millennium Pharmaceuticals, Inc. Signal peptide containing proteins and uses therefor
EP1770160A1 (de) 1998-12-31 2007-04-04 Schering Corporation Nukleinsäuren aus Monocyten und verwandte Zusammensetzungen und Verfahren
GB0510627D0 (en) 2005-05-25 2005-06-29 Avidex Ltd Polypeptides
EP2560001B1 (de) * 2006-09-21 2016-04-13 University of Rochester Zusammensetzungen und Verfahren für eine Proteinverlagerungstherapie für myotone Dystrophie
BRPI1007483B1 (pt) * 2009-01-28 2021-11-30 Bio Preventive Medicine Corporation Método de diagnóstico de nefropatia in vitro, método in vitro para o monitoramento de progresso de nefropatia, método in vitro para o monitoramento da eficácia de um tratamento de nefropatia, método in vitro de avaliação de toxicidade renal de um agente e kit para diagnóstico de nefropatia
EP2334085B1 (de) * 2009-02-05 2019-10-02 Panasonic Intellectual Property Management Co., Ltd. Bildgebungsprozessor
US20120128673A1 (en) 2009-05-20 2012-05-24 Schering Corporation Modulation of pilr receptors to treat microbial infections
WO2011084357A1 (en) 2009-12-17 2011-07-14 Schering Corporation Modulation of pilr to treat immune disorders
JP5791874B2 (ja) * 2010-03-31 2015-10-07 富士フイルム株式会社 着色組成物、インクジェット用インク、カラーフィルタ及びその製造方法、固体撮像素子、並びに表示装置
US20180179274A1 (en) * 2015-06-26 2018-06-28 Institute For Research In Biomedicine Proteins comprising a mutated lair-1 fragment and uses thereof
MX2021000009A (es) 2018-07-09 2021-03-09 Five Prime Therapeutics Inc Anticuerpos de union a transcripcion tipo inmunoglobulina 4 (ilt4).
WO2021222544A1 (en) 2020-05-01 2021-11-04 Ngm Biopharmaceuticals, Inc. Ilt-binding agents and methods of use thereof
WO2023173091A1 (en) 2022-03-11 2023-09-14 Ngm Biopharmaceuticals, Inc. Osteoclast-associated ig-like receptor (oscar) and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04187084A (ja) * 1990-11-22 1992-07-03 Otsuka Pharmaceut Co Ltd 単球表面に発現する抗原及び該抗原に対するモノクローナル抗体
US5314992A (en) * 1991-11-25 1994-05-24 Trustees Of Dartmouth College Lipocortin-1 receptor protein and its uses
US5710262A (en) * 1992-04-17 1998-01-20 Dana-Faber Cancer Institute, Inc. Nucleic acid encoding HB15 polypeptides
US5968768A (en) * 1993-11-02 1999-10-19 Duke University CD6 ligand encoding sequence

Also Published As

Publication number Publication date
CA2273196A1 (en) 1998-06-11
EP2161338A1 (de) 2010-03-10
JP2001507219A (ja) 2001-06-05
EP0948623B1 (de) 2010-01-27
DE69739751D1 (de) 2010-03-18
PT948623E (pt) 2010-05-04
AU5587298A (en) 1998-06-29
EP0948623A2 (de) 1999-10-13
WO1998024906A3 (en) 1998-08-06
CA2273196C (en) 2012-02-07
JP2008109932A (ja) 2008-05-15
WO1998024906A2 (en) 1998-06-11
JP2008194052A (ja) 2008-08-28
ES2338283T3 (es) 2010-05-05
JP4156034B2 (ja) 2008-09-24
JP2009000115A (ja) 2009-01-08

Similar Documents

Publication Publication Date Title
ATE397660T1 (de) Zelloberflächen-antigen aus säugetieren und verwandte reagenzien
LU91756I2 (fr) Denosumab
MY157028A (en) Mammalian cytokine, related reagents
ATE456656T1 (de) Isolierte gene aus säuger monozyten und betreffende reagentien
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
EP1897949A3 (de) Therapeutische Verwendungen von humanem Interleukin-B50
WO1998001557A3 (en) Mammalian chemokine reagents
EP1942114A3 (de) Säuger-Zytokine, zugehörige Reagenzien und Verfahren
WO1998011226A3 (en) Mammalian chemokines, related reagents
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
ATE265533T1 (de) Saeugetierchemokine
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
MX9603266A (es) Genes de timocina de mamiferos.
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
MXPA02004825A (es) Genes especificamente expresados en celulas dendriticas humanas.
WO1998023747A3 (en) Isolated mammalian dendritic cell genes; related reagents
WO2004033648A3 (en) Isolated mammalian membrane protein genes; related reagents
WO2001009176A3 (en) Mammalian cytokines; related reagents
WO1999019491A3 (en) Human dnax interleukin-40 (dil-40)
EP1867720A3 (de) Für Zelloberflächenantigene von Säugetieren kodierende gereinigte Gene; Proteine und Antikörper
ECSP982583A (es) Genes aislados de proteinas de membranas de mamiferos reactivos relacionados

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties